Loading clinical trials...
Loading clinical trials...
The planned study is a prospective analysis of non-psychoactive Cannabidiol (without THC) as an adjunctive therapy for blepharospasm in a masked double cross-over study. This prospective study is a fo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Silkiss Eye Surgery
Collaborators
NCT01668186 · Peroxisome Biogenesis Disorder, Zellweger Spectrum Disorder, and more
NCT07069478 · CBD, Cannabidiol, and more
NCT06514911 · Management of CBD Stones
NCT04680130 · PSP, CBD, and more
NCT05956834 · PSP, CBD, and more
Silkiss Eye Surgery
Oakland, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions